The year 2024 has been remarkable in the fields of tuberculosis and non-tuberculous mycobacteria (NTM) diseases.
The Tuberculosis Network European Trialsgroup (www.tbnet.eu) steering committee is pleased to announce a concise YEAR IN REVIEW of the published scientific literature of 2024. The review covers clinically relevant publications on the epidemiology, prevention, diagnosis and treatment of tuberculosis in children and adults and on diseases caused by non-tuberculous mycobacteria. It lists the best publications, the important new WHO recommendations and provides an algorithm for the treatment of drug-resistant tuberculosis based on latest WHO management guidelines.
“A Year in Review on Tuberculosis and Non-tuberculous Mycobacteria Disease: A 2025 Update for Clinicians and Scientists” is a comprehensive resource for everyone who wishes to be updated on the latest developments in tuberculosis and NTM diseases. Please find the link to the publication at our media partner Pathogens & Immunity open access here: https://doi.org/10.20411/pai.v10i2.791
Many greetings,
Your colleagues from the
TBnet steering committee
Comments